These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23376579)

  • 61. A computer simulation of employee vaccination to mitigate an influenza epidemic.
    Lee BY; Brown ST; Cooley PC; Zimmerman RK; Wheaton WD; Zimmer SM; Grefenstette JJ; Assi TM; Furphy TJ; Wagener DK; Burke DS
    Am J Prev Med; 2010 Mar; 38(3):247-57. PubMed ID: 20042311
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A perspective on multiple waves of influenza pandemics.
    Mummert A; Weiss H; Long LP; Amigó JM; Wan XF
    PLoS One; 2013; 8(4):e60343. PubMed ID: 23637746
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Age-specific contacts and travel patterns in the spatial spread of 2009 H1N1 influenza pandemic.
    Apolloni A; Poletto C; Colizza V
    BMC Infect Dis; 2013 Apr; 13():176. PubMed ID: 23587010
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pandemic (H1N1) 2009 transmission during presymptomatic phase, Japan.
    Gu Y; Komiya N; Kamiya H; Yasui Y; Taniguchi K; Okabe N
    Emerg Infect Dis; 2011 Sep; 17(9):1737-9. PubMed ID: 21888808
    [TBL] [Abstract][Full Text] [Related]  

  • 65. "Wait and see" vaccinating behaviour during a pandemic: a game theoretic analysis.
    Bhattacharyya S; Bauch CT
    Vaccine; 2011 Jul; 29(33):5519-25. PubMed ID: 21601606
    [TBL] [Abstract][Full Text] [Related]  

  • 66. FluTE, a publicly available stochastic influenza epidemic simulation model.
    Chao DL; Halloran ME; Obenchain VJ; Longini IM
    PLoS Comput Biol; 2010 Jan; 6(1):e1000656. PubMed ID: 20126529
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Transmission dynamics of the 2009 influenza A (H1N1) pandemic in India: the impact of holiday-related school closure.
    Ali ST; Kadi AS; Ferguson NM
    Epidemics; 2013 Dec; 5(4):157-63. PubMed ID: 24267871
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antiviral treatment for pandemic influenza: assessing potential repercussions using a seasonally forced SIR model.
    Towers S; Vogt Geisse K; Zheng Y; Feng Z
    J Theor Biol; 2011 Nov; 289():259-68. PubMed ID: 21867715
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A simple mathematical approach to deciding the dosage of vaccine against pandemic H1N1 influenza.
    Nishiura H; Iwata K
    Euro Surveill; 2009 Nov; 14(45):. PubMed ID: 19941790
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.
    Strengell M; Ikonen N; Ziegler T; Kantele A; Anttila VJ; Julkunen I
    Influenza Other Respir Viruses; 2013 May; 7(3):431-8. PubMed ID: 22913369
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inferring epidemic network topology from surveillance data.
    Wan X; Liu J; Cheung WK; Tong T
    PLoS One; 2014; 9(6):e100661. PubMed ID: 24979215
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of vaccines and antivirals during the major 2009 A(H1N1) pandemic wave in Norway--and the influence of vaccination timing.
    Blasio BF; Iversen BG; Tomba GS
    PLoS One; 2012; 7(1):e30018. PubMed ID: 22253862
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Technical guidelines for seasonal influenza vaccination in China (2023-2024)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Oct; 44(10):1507-1530. PubMed ID: 37875437
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Estimation of influenza incidence and analysis of epidemic characteristics from 2009 to 2022 in Zhejiang Province, China.
    Wu H; Xue M; Wu C; Ding Z; Wang X; Fu T; Yang K; Lin J; Lu Q
    Front Public Health; 2023; 11():1154944. PubMed ID: 37427270
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Predictive validation of an influenza spread model.
    Hyder A; Buckeridge DL; Leung B
    PLoS One; 2013; 8(6):e65459. PubMed ID: 23755236
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical, radiological and prognostic features of influenza cases in the influenza epidemic during years 2016-2017.
    Erçen Diken Ö; Arslan S; Akdoğan Ö; Yapar D; Ünal Ö; Demir E; Baykam N
    Tuberk Toraks; 2018 Jun; 66(2):144-149. PubMed ID: 30246658
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Use of an inactivated vaccine in mitigating pandemic influenza A(H1N1) spread: a modelling study to assess the impact of vaccination timing and prioritisation strategies.
    Sypsa V; Pavlopoulou I; Hatzakis A
    Euro Surveill; 2009 Oct; 14(41):19356. PubMed ID: 19883541
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Maternal Influenza Vaccination and the Risk of Laboratory-Confirmed Influenza Among Household Contacts Under the Age of Five in Mali.
    Buchwald AG; Tamboura B; Haidara FC; Coulibaly F; Doumbia M; Diallo F; Boudova S; Keita AM; Sow SO; Kotloff K; Levine M; Tapia MD
    Am J Trop Med Hyg; 2019 Jan; 100(1):159-164. PubMed ID: 30526742
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mitigating effects of vaccination on influenza outbreaks given constraints in stockpile size and daily administration capacity.
    Cruz-Aponte M; McKiernan EC; Herrera-Valdez MA
    BMC Infect Dis; 2011 Aug; 11():207. PubMed ID: 21806800
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An epidemic model with a multistage vaccine.
    DeLegge A; Hunzinger K; Khatri R; Munir K
    Bull Math Biol; 2015 Mar; 77(3):499-513. PubMed ID: 25698086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.